simvastatin has been researched along with Brain Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, L; Manickavasagam, D; Oyewumi, MO | 1 |
| Huang, CJ; Kao, MC; Li, KY; Shih, PC; Tsai, PS; Yang, CH | 1 |
| Dotti, MT; Federico, A | 1 |
| De Liege, P; Gambert, P; Laurent, A; Lecoz, P; Legrand, A; Mikol, J; Peynet, J; Warnet, A | 1 |
4 other study(ies) available for simvastatin and Brain Disorders
| Article | Year |
|---|---|
Nose-to-brain co-delivery of repurposed simvastatin and BDNF synergistically attenuates LPS-induced neuroinflammation.
Topics: Animals; Brain Diseases; Brain-Derived Neurotrophic Factor; Cell Line; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Microglia; Nose; Simvastatin | 2020 |
Simvastatin attenuates sepsis-induced blood-brain barrier integrity loss.
Topics: Animals; Blood Pressure; Blood-Brain Barrier; Brain; Brain Diseases; Chemokine CXCL2; Claudin-3; Claudin-5; Drug Evaluation, Preclinical; Edema; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Male; Malondialdehyde; Oxidative Stress; Random Allocation; Rats, Sprague-Dawley; Sepsis; Simvastatin; Survival Rate | 2015 |
Treatment of cerebrotendinous xanthomatosis.
Topics: Brain Diseases; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Middle Aged; Rhabdomyolysis; Simvastatin; Xanthomatosis | 1994 |
Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings.
Topics: Adult; Anticholesteremic Agents; Brain Diseases; Chenodeoxycholic Acid; Female; Humans; Lovastatin; Muscular Diseases; Simvastatin; Tendons; Tomography, X-Ray Computed; Xanthomatosis | 1991 |